These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28196623)

  • 21. [Use of resources and costs associated with non-adherence to inhaled corticosteroid treatment in asthma].
    Sicras-Mainar A; Huerta A; Sánchez D; Navarro-Artieda R
    Semergen; 2018; 44(1):13-22. PubMed ID: 28456499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
    Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
    J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective comparison of early versus late treatment with fluticasone propionate/salmeterol after an asthma exacerbation.
    Hagiwara M; Delea TE; Stanford RH
    J Asthma; 2011 Sep; 48(7):721-8. PubMed ID: 21793768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma.
    Lefebvre P; Duh MS; Lafeuille MH; Gozalo L; Desai U; Robitaille MN; Albers F; Yancey S; Ortega H; Forshag M; Lin X; Dalal AA
    J Allergy Clin Immunol; 2015 Dec; 136(6):1488-1495. PubMed ID: 26414880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study.
    Yang X; Zhang T; Yang X; Jiang J; He Y; Wang P
    BMC Pulm Med; 2023 Nov; 23(1):463. PubMed ID: 37993799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.
    Yu AP; Yang H; Wu EQ; Setyawan J; Mocarski M; Blum S
    J Med Econ; 2011; 14(3):315-23. PubMed ID: 21500975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand.
    Dilokthornsakul P; Lee TA; Dhippayom T; Jeanpeerapong N; Chaiyakunapruk N
    Value Health Reg Issues; 2016 May; 9():105-111. PubMed ID: 27881251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
    Hagiwara M; Delea TE; Stanford RH
    J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database.
    Lee H; Rhee CK; Lee BJ; Choi DC; Kim JA; Kim SH; Jeong Y; Kim TH; Chon GR; Jung KS; Lee SH; Price D; Yoo KH; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():775-83. PubMed ID: 27143869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence, Characteristics, and Patient Burden of Severe Asthma Determined by Using a Japan Health Care Claims Database.
    Sato K; Ohno T; Ishii T; Ito C; Kaise T
    Clin Ther; 2019 Nov; 41(11):2239-2251. PubMed ID: 31629532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for asthma-related healthcare use: longitudinal analysis using the NHI claims database in a Korean asthma cohort.
    Lee T; Kim J; Kim S; Kim K; Park Y; Kim Y; Lee YS; Kwon HS; Kim SH; Chang YS; Cho YS; Jang AS; Park JW; Nahm DH; Yoon HJ; Cho SH; Cho YJ; Choi BW; Moon HB; Kim TB;
    PLoS One; 2014; 9(11):e112844. PubMed ID: 25397972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Economic Burden of Stroke Based on South Korea's National Health Insurance Claims Database.
    Cha YJ
    Int J Health Policy Manag; 2018 Oct; 7(10):904-909. PubMed ID: 30316242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
    Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct medical cost of Thai pediatric asthma management: a pilot study.
    Puranitee P; Kamchaisatian W; Manuyakorn W; Vilaiyuk S; Laecha O; Pattanaprateep O; Benjaponpitak S
    Asian Pac J Allergy Immunol; 2015 Dec; 33(4):296-300. PubMed ID: 26708393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Barry LE; Sweeney J; O'Neill C; Price D; Heaney LG
    Respir Res; 2017 Jun; 18(1):129. PubMed ID: 28651591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.